共 123 条
[1]
Saeed O(2022)Characteristics and outcomes of patients with COVID-19 supported by extracorporeal membrane oxygenation: a retrospective multicenter study J Thorac Cardiovasc Surg 163 2107-2116.e6
[2]
Tatooles AJ(2021)Extracorporeal membrane oxygenation for COVID-19: updated 2021 guidelines from the extracorporeal life support organization ASAIO J 67 485-495
[3]
Farooq M(2021)Extracorporeal membrane oxygenation in patients with severe respiratory failure from COVID-19 Intensive Care Med 47 208-221
[4]
Badulak J(2022)Evolving outcomes of extracorporeal membrane oxygenation during the first 2 years of the COVID-19 pandemic: a systematic review and meta-analysis Crit Care 26 147-862
[5]
Antonini MV(2021)Extracorporeal membrane oxygenation for COVID-19: a systematic review and meta-analysis Crit Care 25 211-2706
[6]
Stead CM(2021)Evolving outcomes of extracorporeal membrane oxygenation support for severe COVID-19 ARDS in sorbonne hospitals Paris Crit Care 25 355-1131
[7]
Shaefi S(2021)Extracorporeal membrane oxygenation network organisation and clinical outcomes during the COVID-19 pandemic in Greater Paris, France: a multicentre cohort study Lancet Respir Med 9 851-1052
[8]
Brenner SK(2022)ECMO in COVID-19 patients: a systematic review and meta-analysis J Cardiothorac Vasc Anesth 36 2700-298
[9]
Gupta S(2020)Hemocompatibility-related adverse events and survival on venoarterial extracorporeal life support: an ELSO registry analysis JACC Heart Fail 8 1121-747
[10]
Ling RR(2022)Bleeding and thrombotic events in adults supported with venovenous extracorporeal membrane oxygenation: an ELSO registry analysis Intensive Care Med 48 1039-907